CENTENE CORP 8-K

What Happened

• Centene Corporation (CNC) announced it presented at the Barclays 28th Annual Global Healthcare Conference on March 10, 2026 (8:30 a.m. EDT) and reaffirmed its 2026 full-year guidance: GAAP diluted EPS > $1.98 and adjusted diluted EPS > $3.00.
• On March 10, 2026 the company delivered a notice to partially redeem $1,000,000,000 aggregate principal amount of its 4.25% Notes due December 15, 2027; the redemption date is March 25, 2026.

Key Details

• Presentation webcast was available live on March 10, 2026 and a replay will be posted on Centene’s investor website.
• Centene reaffirmed 2026 guidance of: GAAP diluted EPS greater than $1.98 and adjusted diluted EPS greater than $3.00 (see Feb. 6, 2026 press release Exhibit 99.1 for GAAP-to-adjusted reconciliation).
• Debt action: $1.0 billion of 4.25% Notes due 12/15/2027 to be redeemed at 100% of principal plus accrued interest on March 25, 2026; about $1,186,664,000 of those notes will remain outstanding after the redemption.
• The redemption follows the Indenture dated December 6, 2019 with The Bank of New York Mellon Trust Company, N.A. as trustee.

Why It Matters

• Reaffirmed EPS guidance provides investors with management’s current outlook for 2026 earnings on both GAAP and adjusted bases, and points to confidence in near-term financial performance (subject to the forward‑looking statement risks described by the company).
• The $1.0 billion partial redemption reduces Centene’s near-term outstanding 2027 debt, which may affect the company’s leverage and interest obligations; the redemption is at par plus accrued interest and leaves roughly $1.19 billion of the 2027 notes outstanding.
• Investors should review the company’s reconciliations and earlier filings (including the Feb. 6, 2026 press release) and note that the guidance is forward-looking and subject to risks and uncertainties disclosed in Centene’s SEC filings.